Thousands to Walk Ahead for Brain Tumor Research Sunday
CINCINNATIOn Sunday, Oct. 25, more than 3,000 walkers and runners will pound the pavement in the sixth annual Walk Ahead for a Brain Tumor Cure. Already, the 2015 Walk Ahead has raised more than $276,000 for education and research at the Brain Tumor Center at the University of Cincinnati (UC) Neuroscience Institute and the UC Cancer Institute. The institutes are collaborations of the UC College of Medicine and UC Health.
Walk Ahead for a Brain Tumor Cure has raised more than $1.2 million for Cincinnati programs since its inception in 2010.
An estimated 215,000 brain tumors are diagnosed in the United States each year; of these, 45,000 have originated in the brain and 170,000 have metastasized from other parts of the body.
Patients, physicians and researchers of the UC Brain Tumor Center will be available for interviews before, during and after the Oct. 25 event.
Walk Ahead 5k Schedule
7 a.m.: Same-day registration opens
8 a.m.: Shotgun start for chip-timed 5K run, beginning at Yeatmans Cove, Sawyer Point
8:45 a.m.: Shotgun start for 5k walk, beginning at Yeatmans Cove, Sawyer Point
More information:
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.